two sided debridement pad
Devicetwo sided debridement pad
NCT Number: NCT07312513
The aim of this post market clinical follow up (PMCF) study is to confirm the performance of Debrisoft® Duo, to collect safety data regarding expected adverse events and to detect potential unexpected adverse events associated with the use of Debrisoft® Duo within the certified indications and under the conditions of routine use.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
MIKOMED Sp. z.o.o., Lodz, Poland
This clinical investigation will be conducted as multicenter, randomized in parallel groups, non-inferiority controlled trial. After randomization patients will receive wound debrided with the investigational device or the comparator device during one study visit. During the study visit patients will have clinical examination and wound photos will be taken.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
two sided debridement pad
one sided debridment pad
Time frame: 1 day
Wound photos will be taken. On these photos, the amount of fibrinous and necrotic tissue/slough/debris in the wound bed before and after debridement will be measured by W.H.A.T. (Wound Healing Analyzing Tool).
Time frame: 1 day
The amount of fibrinous and necrotic tissue/slough/debris in the wound bed before and after debridement will be measured by the investigator.
Time frame: 1 day
Frequency and character of device deficiencies (DDs), adverse events (AEs), serious adverse events (SAEs), adverse device effects (ADEs), serious adverse device effects (SADEs) and incidents.
Time frame: 1 day
Time frame: 1 day
Wound related pain will be measured directly before, during and 10 +/-2 minutes using NRS-11 scale
Time frame: 1 day
Time needed for the debridement procedure will be assessed using a stopper
Time frame: 1 day
Amount of products that were used during one debridement session will be assessed.
Time frame: 1 day
Patient satisfaction with the treatment procedure on a scale from 1-5
Time frame: 1 day
User satisfaction assessed via a questionnaire
Time frame: 1 day
Wound size will be compared before and after the debridement procedure
Time frame: 1 day
If performed during clinical routine, results of biopsy or smear will be assessed
Time frame: 1 day
Change in the presence of biofilm before and after debridement will be investigated using MolecuLightDX. This will only be done at one of the five participating sites.
Contact information is provided by the study sponsor or research team.
Lohmann & Rauscher
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07255937
Arterial Leg Ulcer, Burns
Madrid, Spain
View Trial DetailsNCT03070925
Cardiovascular Diseases, Diabetic Ulcers
Lake Success, New York, United States
View Trial DetailsNCT05646121
Arterial Ulcers, Cardiovascular Diseases
Bolesławiec, Poland
View Trial DetailsNCT01348581
Cardiovascular Diseases, Chronic Disease
Reykjavik, Iceland
View Trial Details